More progress needed for hep C elimination in country of Georgia

More progress needed for hep C elimination in country of georgia

(HealthDay)—More interventions are needed to meet the target of hepatitis C virus (HCV) elimination, defined as a 90 percent reduction in prevalence by 2020, in the country of Georgia, according to research published in the July 28 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that in April 2015, Georgia embarked on the world's first program to eliminate HCV, with technical assistance from the U.S. Centers for Disease Control and Prevention, Muazzam Nasrullah, M.D., Ph.D., from the CDC in Atlanta, and colleagues present the progress toward this goal.

Through partnership with Gilead Sciences, the country committed to identifying infected individuals and linking them to care and curative antiviral therapy. The researchers found that 27,595 persons initiated treatment from April 2015 through December 2016, and 71.7 percent completed treatment. Overall, 84.1 percent of the 6,366 persons tested for HCV RNA ≥12 weeks after completing treatment had no detectable virus in their blood, indicating sustained virologic response. The peak number of persons initiating treatment occurred in September 2016 at 4,595, and subsequently decreased in October to December.

"Broader implementation of interventions that increase access to HCV testing, care, and for persons living with HCV are needed for Georgia to reach national targets for the elimination of HCV," the authors write.

Gilead Sciences had no role in the conduct of the research or preparation of the report.


Explore further

HIV testing inadequate in young men who have sex with men

More information: Abstract/Full Text

Copyright © 2017 HealthDay. All rights reserved.

Citation: More progress needed for hep C elimination in country of Georgia (2017, July 31) retrieved 1 October 2020 from https://medicalxpress.com/news/2017-07-hep-country-georgia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments